GENEVA, July 2 -- NXERA PHARMA UK LIMITED filed a patent application (GB2025/060064) for “SULFONAMIDE DERIVATIVES USEFUL AS GPR17 MODULATORS”. With publication no. WO/2026/132834, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07D 471/00
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....